Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

New schools, restructuring part of streamlined Faculty of Health Sciences
2017-10-12

 Description: Health Sciences staff 2 Tags: Faculty of Health Sciences, five-school structure, Prof Gert van Zyl, Pathology, Biomedical Sciences  

From the left, front are: Dr Jocelyn Naicker,
Prof Gert van Zyl, Prof Magda Mulder;
back from left: Prof Chris Viljoen,
Marlene Viljoen, Deputy Director: Faculty of Health Sciences;
Prof Nathaniel Mofolo; and Prof Santie van Vuuren.
Photo: Rulanzen Martin


Numerous developments, such as the creation of two new schools and one newly restructured School of Medicine in the Faculty of Health Sciences at the University of the Free State (UFS), will catapult this renowned faculty to even greater heights.

Five-school structure to increase access
 
A five-school structure was proposed at the annual Faculty Management retreat in July 2016. The previous three-school model included the Schools of Medicine, Nursing, and Allied Health Professions.

The current School of Medicine has been restructured and will henceforth be known as the School of Clinical Medicine. The Schools of Pathology and Biomedical Sciences have been added to the faculty. “So, three new schools were in fact created within the faculty,” said Prof Gert van Zyl, Dean of the faculty.   

“There was also a request from the National Health Laboratory Services to group academics that is rendering services in pathology into a new School of Pathology.” This is what motivated the faculty management to create two new schools.

Esteemed academics appointed 

With the creation of the new schools, there were also new appointments within the Faculty of Health Sciences. Dr Jocelyn Naicker has been appointed as the new part-time Head of the School of Pathology, Prof Chris Viljoen was appointed as the part-time Head of the School of Biomedical Sciences, and Prof Nathaniel Mofolo as the new Head of the School of Clinical Medicine. Prof Santie van Vuuren remains Head of the School of Allied Health Professions, and Prof Magda Mulder as the head of the School of Nursing. 

Research outputs to remain as usual
The addition of the new schools will not impact research output. “In the past, research was done across departmental boundaries between all the departments in the faculty,” Prof Van Zyl said. The advantages of adding two additional schools are that the workload will be distributed among the five schools. The heads of schools will work within their respective disciplines and related areas, and will eliminate the duplication of administrative functions.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept